TR201900778T4 - İmmünojenik bileşim. - Google Patents
İmmünojenik bileşim. Download PDFInfo
- Publication number
- TR201900778T4 TR201900778T4 TR2019/00778T TR201900778T TR201900778T4 TR 201900778 T4 TR201900778 T4 TR 201900778T4 TR 2019/00778 T TR2019/00778 T TR 2019/00778T TR 201900778 T TR201900778 T TR 201900778T TR 201900778 T4 TR201900778 T4 TR 201900778T4
- Authority
- TR
- Turkey
- Prior art keywords
- protein
- saccharide
- saccharides
- meningitidis
- polysaccharides
- Prior art date
Links
- 230000002163 immunogen Effects 0.000 title abstract 2
- 150000001720 carbohydrates Chemical class 0.000 abstract 4
- 150000004676 glycans Chemical class 0.000 abstract 4
- 229920001282 polysaccharide Polymers 0.000 abstract 4
- 239000005017 polysaccharide Substances 0.000 abstract 4
- 108090000623 proteins and genes Proteins 0.000 abstract 4
- 102000004169 proteins and genes Human genes 0.000 abstract 4
- 102000014914 Carrier Proteins Human genes 0.000 abstract 2
- 108010078791 Carrier Proteins Proteins 0.000 abstract 2
- 241000588650 Neisseria meningitidis Species 0.000 abstract 2
- 230000021615 conjugation Effects 0.000 abstract 2
- 108010071134 CRM197 (non-toxic variant of diphtheria toxin) Proteins 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
- A61K2039/627—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN281MU2012 | 2012-01-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR201900778T4 true TR201900778T4 (tr) | 2019-02-21 |
Family
ID=54259032
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2019/00778T TR201900778T4 (tr) | 2012-01-30 | 2013-01-29 | İmmünojenik bileşim. |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US9198977B2 (enExample) |
| EP (1) | EP2809349B1 (enExample) |
| JP (1) | JP6042455B2 (enExample) |
| KR (1) | KR101897317B1 (enExample) |
| CN (1) | CN104302315B (enExample) |
| BR (1) | BR112014018815B1 (enExample) |
| CA (1) | CA2863178C (enExample) |
| DK (1) | DK2809349T3 (enExample) |
| ES (1) | ES2707294T3 (enExample) |
| HU (1) | HUE040914T4 (enExample) |
| MX (1) | MX354103B (enExample) |
| PT (1) | PT2809349T (enExample) |
| RU (1) | RU2634405C2 (enExample) |
| SG (1) | SG11201404447WA (enExample) |
| SI (1) | SI2809349T1 (enExample) |
| TR (1) | TR201900778T4 (enExample) |
| WO (1) | WO2013114268A1 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008543907A (ja) * | 2005-06-27 | 2008-12-04 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | 免疫原性組成物 |
| WO2014080423A2 (en) * | 2012-11-21 | 2014-05-30 | Serum Institute Of India Ltd. | Production of high yields of bacterial polysaccharides |
| AU2014313699B2 (en) * | 2013-08-24 | 2019-12-19 | Bharat Biotech International Limited | A bacterial vaccine and methods for manufacture thereof |
| EP2921856B1 (en) | 2014-03-18 | 2016-09-14 | Serum Institute Of India Private Limited | A quantitative assay for 4-pyrrolidinopyridine (4-ppy) in polysaccharide-protein conjugate vaccines |
| EP3302542A4 (en) * | 2015-06-08 | 2019-04-10 | Serum Institute Of India Private Limited | METHOD FOR IMPROVING ADSORPTION OF POLYSACCHARIDE PROTEIN CONJUGATES AND POLYVALENT VACCINE FORMULATION THEREOF |
| AU2016290233A1 (en) * | 2015-07-04 | 2018-01-25 | Bharat Biotech International Limited | Polysaccharide vaccine formulations and processes for industrial production of bacterial polysaccharides |
| BR112018068523A2 (pt) * | 2016-03-15 | 2019-01-22 | Msd Wellcome Trust Hilleman Laboratories Pvt Ltd | novos conjugados de polissacarídeo-proteína e processo para obter os mesmos |
| CN106110316A (zh) * | 2016-06-27 | 2016-11-16 | 北京智飞绿竹生物制药有限公司 | 一种肺炎球菌结合物组合疫苗的制备方法 |
| PT3506935T (pt) * | 2016-09-02 | 2024-04-01 | Sanofi Pasteur Inc | Vacina contra neisseria meningitidis |
| CN106397537B (zh) * | 2016-10-13 | 2020-01-07 | 李红臣 | 一种高效快速的多糖蛋白结合疫苗纯化分析方法 |
| CN110831980B (zh) | 2017-05-05 | 2022-09-27 | 血清研究所印度私人有限公司 | 用于从细菌荚膜多糖基制剂中去除杂质的方法 |
| US20200147198A1 (en) * | 2017-06-27 | 2020-05-14 | MSD Wellcome Trust Hiiieman Laboratories PVT., Ltd. | Novel Multivalent Polysaccharide-Protein Conjugate Vaccine Composition and Formulation Thereof |
| US20200353064A1 (en) * | 2018-01-29 | 2020-11-12 | Msd Wellcome Trust Hilleman Laboratories Pvt. Ltd. | Novel meningococcal vaccine composition and process thereof |
| WO2019198096A1 (en) * | 2018-04-11 | 2019-10-17 | Msd Wellcome Trust Hilleman Laboratories Pvt. Ltd. | Tetravalent meningococcal vaccine composition and process to prepare thereof |
| JOP20200214A1 (ar) | 2019-09-03 | 2021-03-03 | Serum Institute Of India Pvt Ltd | تركيبات مولدة للمناعة ضد الأمراض المعوية وطرق لتحضيرها |
| KR102871663B1 (ko) | 2019-09-27 | 2025-10-16 | 화이자 인코포레이티드 | 네이세리아 메닌기티디스 조성물 및 그의 방법 |
| JP7630603B2 (ja) | 2020-08-10 | 2025-02-17 | インベントプライズ・インコーポレイテッド | 出現血清型２４ｆを含む多価肺炎球菌複合糖質ワクチン |
| CN118078981A (zh) * | 2024-04-26 | 2024-05-28 | 成都康华生物制品股份有限公司 | 一种基于双蛋白载体的五价脑膜炎球菌多糖结合疫苗的制备方法及其产品 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2763244B1 (fr) * | 1997-05-14 | 2003-08-01 | Pasteur Merieux Serums Vacc | Composition vaccinale multivalente a porteur mixte |
| EP2279748A1 (en) * | 2000-06-29 | 2011-02-02 | SmithKline Beecham Biologicals S.A. | Multivalent vaccine composition |
| GB0115176D0 (en) * | 2001-06-20 | 2001-08-15 | Chiron Spa | Capular polysaccharide solubilisation and combination vaccines |
| GB0130215D0 (en) * | 2001-12-18 | 2002-02-06 | Glaxosmithkline Biolog Sa | Vaccine |
| SI1670506T1 (sl) * | 2003-10-02 | 2013-03-29 | Novartis Ag | Tekoča cepiva proti multiplim meningokoknim seroskupinam |
| JP2008543907A (ja) * | 2005-06-27 | 2008-12-04 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | 免疫原性組成物 |
| GB0513069D0 (en) * | 2005-06-27 | 2005-08-03 | Glaxosmithkline Biolog Sa | Immunogenic composition |
| CA2621023C (en) * | 2005-09-01 | 2019-07-02 | Novartis Vaccines And Diagnostics Gmbh & Co. Kg | Multiple vaccination including serogroup c meningococcus |
| EA014107B1 (ru) * | 2005-12-22 | 2010-10-29 | Глаксосмитклайн Байолоджикалс С.А. | Вакцина, содержащая конъюгаты капсульных полисахаридов streptococcus pneumoniae |
| GB0703369D0 (en) * | 2007-02-21 | 2007-03-28 | Health Prot Agency | Compositions Comprising Capsular Polysaccharides and Their Use as Vaccines |
| SG10201506160VA (en) * | 2009-12-17 | 2015-09-29 | Fina Biosolutions Llc | Chemical reagents for the activation of polysaccharides in the preparation of conjugate vaccines |
| ES2820898T3 (es) * | 2012-05-22 | 2021-04-22 | Glaxosmithkline Biologicals Sa | Conjugado del serogrupo X de meningococos |
-
2013
- 2013-01-29 US US14/375,385 patent/US9198977B2/en active Active
- 2013-01-29 CN CN201380017781.9A patent/CN104302315B/zh active Active
- 2013-01-29 PT PT13743463T patent/PT2809349T/pt unknown
- 2013-01-29 ES ES13743463T patent/ES2707294T3/es active Active
- 2013-01-29 DK DK13743463.5T patent/DK2809349T3/da active
- 2013-01-29 BR BR112014018815-7A patent/BR112014018815B1/pt active IP Right Grant
- 2013-01-29 KR KR1020147024348A patent/KR101897317B1/ko active Active
- 2013-01-29 TR TR2019/00778T patent/TR201900778T4/tr unknown
- 2013-01-29 CA CA2863178A patent/CA2863178C/en active Active
- 2013-01-29 EP EP13743463.5A patent/EP2809349B1/en active Active
- 2013-01-29 WO PCT/IB2013/050739 patent/WO2013114268A1/en not_active Ceased
- 2013-01-29 SI SI201331329T patent/SI2809349T1/sl unknown
- 2013-01-29 RU RU2014134288A patent/RU2634405C2/ru active
- 2013-01-29 SG SG11201404447WA patent/SG11201404447WA/en unknown
- 2013-01-29 MX MX2014009250A patent/MX354103B/es active IP Right Grant
- 2013-01-29 HU HUE13743463A patent/HUE040914T4/hu unknown
- 2013-01-29 JP JP2014555364A patent/JP6042455B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| RU2014134288A (ru) | 2016-03-20 |
| CA2863178C (en) | 2021-04-06 |
| RU2634405C2 (ru) | 2017-10-26 |
| DK2809349T3 (da) | 2019-02-18 |
| CN104302315B (zh) | 2018-02-06 |
| SI2809349T1 (sl) | 2019-03-29 |
| PT2809349T (pt) | 2019-02-01 |
| EP2809349A1 (en) | 2014-12-10 |
| EP2809349B1 (en) | 2018-12-19 |
| MX354103B (es) | 2018-02-13 |
| US20140377302A1 (en) | 2014-12-25 |
| BR112014018815B1 (pt) | 2022-07-12 |
| CN104302315A (zh) | 2015-01-21 |
| SG11201404447WA (en) | 2014-08-28 |
| JP6042455B2 (ja) | 2016-12-14 |
| BR112014018815A8 (pt) | 2017-07-11 |
| US9198977B2 (en) | 2015-12-01 |
| KR20140123553A (ko) | 2014-10-22 |
| HUE040914T4 (hu) | 2019-05-28 |
| EP2809349A4 (en) | 2015-08-26 |
| WO2013114268A1 (en) | 2013-08-08 |
| BR112014018815A2 (enExample) | 2017-06-20 |
| CA2863178A1 (en) | 2013-08-08 |
| ES2707294T3 (es) | 2019-04-03 |
| MX2014009250A (es) | 2015-03-19 |
| JP2015509111A (ja) | 2015-03-26 |
| KR101897317B1 (ko) | 2018-09-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR201900778T4 (tr) | İmmünojenik bileşim. | |
| PH12021551159A1 (en) | Compositions and methods for preparing staphylococcus aureus serotype 5 and 8 capsular polysaccharide conjugate immunogenic compositions | |
| MX2025002072A (es) | Un conjugado de un agente citotoxico y una molecula de union a celulas con enlazadores ramificados | |
| MY148110A (en) | Immunogenic composition | |
| BR112012019757B8 (pt) | Composição imunogênica, e, uso de uma mistura de conjugado de polissacarídeo-proteína multivalente | |
| PH12018501517B1 (en) | Neisseria meningitidis compositions and methods thereof | |
| EP2408470A4 (en) | SOLUBLE NONDEPOT INSULIN CONJUGATE AND ITS USE | |
| JP2014218516A5 (enExample) | ||
| NZ739788A (en) | Phthalocyanine dye conjugates and their storage | |
| EA201290690A1 (ru) | Иммуногенная композиция, содержащая полисахариды s.pneumoniae, конъюгированные с белками-носителями | |
| NZ595291A (en) | Combinations of meningococcal factor h binding protein and pneumococcal saccharide conjugates | |
| AR060187A1 (es) | Composicion inmunogenica | |
| RU2009130447A (ru) | Модифицированные сахариды | |
| CL2016000566A1 (es) | Método para para preparar una composición inmunogénica multivalente que comprende 13 conjugados de un serotipo diferente de streptococcus pneumoniae, donde cada uno de los conjugados contiene un polisacárido capsular diferente conjugado a la proteína portadora crm197. div. sol. madre n° 200600802 e hija cl 201702206. | |
| JP2015518845A5 (enExample) | ||
| RU2014151567A (ru) | Конъюгат менингококка серогруппы х | |
| IN2014DN09791A (enExample) | ||
| BR112019001995A2 (pt) | composição de conjugado de polissacarídeo pneumocócico multivalente ? proteína | |
| IN2012MN02262A (enExample) | ||
| HRP20090607T8 (en) | Combined meningococcal conjugates with common carrier protein | |
| HRP20240433T1 (hr) | Cjepivo protiv neisseria meningitidis | |
| RU2007102016A (ru) | Пространственный анализ конъюгатов сахаридов с помощью gpc и sec-mals | |
| BRPI0411875A (pt) | método de imunização contra os sorogrupos a e c de neisseria meningitidis | |
| WO2015052684A3 (en) | Polysaccharide-protein conjugates with enhanced immunogenicity and rapid high yielding process of preparation thereof | |
| FI2968427T3 (fi) | Konjugaatti sienisoluseinämän polysakkarideihin kohdentuvien vasta-aineiden indusoimiseksi |